About AllerGenis
AllerGenis is a Healthcare company based in Hatfield (United States) founded in 2017 by Jim Garner. It develops accurate allergy testing solutions for healthcare providers and patients. It operates on a B2B model. Its chief executive is Jim Garner. AllerGenis offers products and services including Peanut Diagnostic Test. Its focus areas include Biotech, Diagnostics and Allergy Testing. Its legal entity is AllerGenis, Inc. Its competitors include Allergy Amulet, YorkTest, Microtest Diagnostics, ATANIS Biotech and DST and 3 more; 3 of its 8 listed competitors have raised funding.
Company details
Allergenis is a company based in Wynnewood, Pennsylvania, USA, that specializes in developing precision diagnostic tools for food allergies. They use advanced techniques like bead-based epitope assays to provide highly accurate results for peanut allergies. The firm collaborates with experts, offers resources such as webinars, and serves healthcare providers by enabling better management of patient allergies through reliable testing and data analysis.
- Headquarters Hatfield, United States
- Founders Jim Garner
- SectorsHealthcare
- Email••••••••
- Website allergenis.com
- Social LinkedIn X Facebook Instagram
- Legal Name Allergenis, Inc.
- Annual Revenue$486 K (USD)0as on Dec 31, 2023
Products & Services of AllerGenis
AllerGenis offers a comprehensive portfolio of products and services, including Peanut Diagnostic Test.
Accurate assay for diagnosing peanut allergies in patients.
People of AllerGenis
37 people are tracked at AllerGenis (4 in leadership, 26 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Jim Garner | Founder, CEO | Leadership |
Kristy Consalvo | Head Of Marketing | Leadership |
Thomas Vollmers | Head - Strategic Partnerships and Commercial Strategy | Leadership |
Ben Gerson | Clinical Laboratory Director | Leadership |
Al Luderer | Chair | Board & advisors |
Vijay Aggarwal | Board Member | Board & advisors |
David Esposito | Board Member | Board & advisors |
Russ Fein | Board Member, Acting CFO | Board & advisors |
David Fleischer | Advisor | Board & advisors |
Matthew Greenhawt | Advisor | Board & advisors |
Hugh Sampson | Board Member | Board & advisors |
John Simons | Board Member | Board & advisors |
Sharon Chinthrajah | Advisor | Board & advisors |
Drew Bird | Advisor | Board & advisors |
Ruchi Gupta | Advisor | Board & advisors |
David Brown | Advisor | Board & advisors |
Dianne Campbell | Advisor | Board & advisors |
BJ Lanser | Advisor | Board & advisors |
Edmond Chan | Advisor | Board & advisors |
Robert Hamilton | Advisor | Board & advisors |
17 more people are available in the full profile.
Complete people profiles for AllerGenis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of AllerGenis
AllerGenis has 8 listed competitors in our database, 3 of them funded. They include Allergy Amulet, YorkTest, Microtest Diagnostics, ATANIS Biotech and DST, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| allergyamulet.com | 2016 | Madison, United States | $12.57M | – | Portable food allergen sensors are offered via an online platform. | |
| yorktest.com | 1982 | York, United Kingdom | $12.03M | 38 | At-home food and allergy test kits are developed by YorkTest. | |
| microtestdx.com | 2002 | London, United Kingdom | $2.5M | 6 | Functions as an automated allergy testing service. | |
| atanis-biotech.com | 2021 | Sursee, Switzerland | – | – | Developer of a cell-based assay for the diagnosis of allergies | |
| dst-diagnostic.com | 2005 | Schwerin, Germany | – | 42 | Innovative in-vitro diagnostic solutions are developed by DST. | |
| immunovent.com | 2012 | New York, United States | – | – | Diagnostic tests for allergies are developed using mucosal brush samples. | |
| macroarraydx.com.ua | 2016 | Kiev, Ukraine | – | – | Allergen analyzers are provided for in-vitro IgE level determination. | |
| bangqibio.tcc.mode | 2020 | Suzhou, China | – | – | Instruments and reagents for immune disorder diagnosis are developed. |
Detailed competitors of AllerGenis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as AllerGenis (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | – | 336 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Allergenis
Complete news archive for AllerGenis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AllerGenis
AllerGenis was founded in 2017.
AllerGenis is headquartered in Hatfield, United States.
Jim Garner is the current CEO of AllerGenis. They have also founded this company.
Annual revenue of AllerGenis is $486K as on Dec 31, 2023.
Allergenis is a company based in Wynnewood, Pennsylvania, USA, that specializes in developing precision diagnostic tools for food allergies. They use advanced techniques like bead-based epitope assays to provide highly accurate results for peanut allergies. The firm collaborates with experts, offers resources such as webinars, and serves healthcare providers by enabling better management of patient allergies through reliable testing and data analysis.
AllerGenis's top competitors include Allergy Amulet, ATANIS Biotech and YorkTest.
AllerGenis offers Peanut Diagnostic Test.
AllerGenis operates through Allergenis, Inc..